Our Pricing

Mounjaro And Hypothyroidism: What Side Effects To Expect?

Published on: June 03, 2026

If you're considering mounjaro and hypothyroidism uk treatment together, understanding the interaction between tirzepatide and thyroid conditions is essential. At Cured Pharmacy, our UK-registered clinical team assesses every patient individually to ensure Mounjaro is safe and appropriate for those managing underactive thyroid conditions.

Can You Take Mounjaro With Hypothyroidism?

Mounjaro (tirzepatide) can generally be prescribed to patients with well-controlled hypothyroidism, but it requires careful clinical assessment by a UK prescriber [1]. Hypothyroidism itself does not automatically exclude you from Mounjaro treatment, though your thyroid function and current medication regimen must be evaluated before starting.

The critical consideration is thyroid C-cell tumour risk. In animal studies, GLP-1 receptor agonists including tirzepatide caused thyroid C-cell tumours at clinically relevant exposures [1]. While this has not been established in humans, the MHRA advises caution in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [2].

Patients taking levothyroxine or other thyroid replacement therapy can typically use Mounjaro safely, but thyroid function tests (TSH, T4) should be monitored regularly throughout treatment. Your UK prescriber will review your most recent thyroid results during your clinical assessment to confirm suitability.

Mounjaro Side Effects Specific To Thyroid Patients

The most common side effects of Mounjaro — nausea, vomiting, diarrhoea, and reduced appetite — occur in both thyroid patients and the general population [1]. In the SURPASS clinical trial programme, gastrointestinal side effects were reported in up to 30% of participants, typically mild to moderate and decreasing over time [3].

For patients with hypothyroidism, there are additional monitoring considerations. Rapid weight loss from Mounjaro may alter your thyroid hormone requirements, potentially necessitating dose adjustments to your levothyroxine or liothyronine [2]. Symptoms of under-replacement (fatigue, weight gain, cold intolerance) or over-replacement (palpitations, anxiety, tremor) should be reported to your GP promptly.

Gastrointestinal side effects from Mounjaro can theoretically affect absorption of oral thyroid medication if taken simultaneously. To optimise levothyroxine absorption, continue taking it on an empty stomach at least 30 minutes before food or other medications, as standard clinical guidance recommends [4].

Warning Signs To Watch For

Contact your healthcare provider immediately if you experience a lump or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath while taking Mounjaro. These could indicate thyroid C-cell tumour development, though this remains extremely rare in human patients [2].

Regular thyroid function monitoring every 8-12 weeks during the initial Mounjaro titration phase allows early detection of any hormone imbalance requiring levothyroxine dose modification.

Mounjaro And Levothyroxine: Drug Interactions

There is no direct pharmacokinetic interaction between tirzepatide and levothyroxine — they do not chemically interfere with each other's metabolism or efficacy [1]. However, Mounjaro slows gastric emptying, which may theoretically delay absorption of oral medications taken around the same time.

Clinical guidance recommends continuing your established levothyroxine routine: take it first thing in the morning on an empty stomach, at least 30-60 minutes before breakfast or other medications [4]. This timing ensures optimal absorption regardless of Mounjaro's gastric effects.

If you take other thyroid medications such as liothyronine (T3), the same principles apply. Your UK prescriber will review all current medications during your Mounjaro consultation to identify any timing adjustments needed for optimal efficacy.

Mounjaro Dosing For Patients With Hypothyroidism

The standard Mounjaro titration schedule applies to thyroid patients: starting at 2.5mg once weekly for four weeks, then increasing to 5mg weekly [1]. Further dose escalation to 7.5mg, 10mg, 12.5mg, or 15mg occurs at four-week intervals based on tolerability and weight loss response.

Patients with hypothyroidism do not require dose adjustments to Mounjaro itself, but your thyroid medication may need modification as weight loss progresses. In clinical practice, significant weight reduction can decrease thyroid hormone requirements by 10-25% in some patients [4].

Your UK prescriber will determine your appropriate starting dose during the online clinical assessment. All Mounjaro treatment at Cured Pharmacy includes ongoing monitoring and dose titration support from our UK-registered clinical team.

Monitoring Your Thyroid During Treatment

Request thyroid function tests from your GP at baseline (before starting Mounjaro) and every 8-12 weeks during the first six months of treatment. This allows early detection of any TSH or T4 changes requiring levothyroxine adjustment.

Keep a symptom diary noting energy levels, temperature tolerance, heart rate, and mood changes. These subjective markers often indicate thyroid imbalance before blood tests become abnormal, enabling proactive dose optimisation.

Weight Loss Results: Mounjaro And Hypothyroidism

Patients with well-controlled hypothyroidism achieve comparable weight loss results to the general population when using Mounjaro. In the SURPASS-3 trial, participants on 15mg tirzepatide lost an average of 22.5% body weight over 72 weeks [3].

Uncontrolled hypothyroidism (elevated TSH, low T4) may blunt weight loss response due to reduced metabolic rate, which is why thyroid optimisation before starting Mounjaro is essential. Your UK prescriber will review recent thyroid function tests to confirm adequate replacement therapy.

Some thyroid patients report improved energy levels and reduced fatigue as weight decreases, even with stable levothyroxine dosing. This likely reflects reduced inflammatory burden and improved insulin sensitivity rather than direct thyroid effects [4].

Getting Mounjaro With Hypothyroidism At Cured Pharmacy

Cured Pharmacy offers Mounjaro from £124.99 with a free online clinical assessment completed in under three minutes. Our UK-registered prescribers review your thyroid history, current medications, and recent blood test results to confirm suitability.

During your consultation, you'll be asked about your hypothyroidism diagnosis, current levothyroxine dose, most recent TSH result, and any family history of thyroid cancer. This information allows our clinical team to make an informed prescribing decision in line with MHRA safety guidance [2].

All Mounjaro pens dispensed by Cured Pharmacy are genuine UK-licensed medication supplied in discreet packaging with next-day delivery options. Ongoing prescription management and dose titration support are included at no additional cost, with direct access to our superintendent pharmacist Tarun Kumar (GPhC 2233073) for any clinical queries.

What You'll Need For Your Assessment

Have your current levothyroxine dose and most recent thyroid function test results (TSH and T4) available during your online consultation. Results from the past six months are acceptable, though more recent values provide better clinical context.

If you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, inform your prescriber during assessment. These conditions are contraindications to Mounjaro treatment under current MHRA guidance [2].

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14617/smpc [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Glucagon-like peptide-1 (GLP-1) receptor agonists: reports of thyroid cancer. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Thyroid disease: assessment and management (NG145). https://www.nice.org.uk/guidance/ng145 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication, particularly if you have thyroid conditions or are taking levothyroxine or other thyroid replacement therapy.